期刊
PSYCHOPHARMACOLOGY
卷 227, 期 1, 页码 93-100出版社
SPRINGER
DOI: 10.1007/s00213-012-2942-3
关键词
Type 2 diabetes; Cognition; Brain-derived neurotrophic factor; Serum
资金
- Stanley Medical Research Institute [03 T-459, 05 T-726]
- Department of Veterans Affairs
- Mental Illness Research, Education and Clinical Center (MIRECC)
- United States National Institute of Health [K05-DA0454, P50-DA18827, U01-MH79639]
- [VISN 16]
Studies suggest that brain-derived neurotrophic factor (BDNF) plays an essential role in regulating memory-related neuroplasticity in the hippocampus. Type 2 diabetes (T2DM) is associated with impairment in many domains of cognitive function which may result from reduced BDNF; however, the correlation of BDNF with cognitive impairment in T2DM has not been investigated. We compared 208 patients with T2DM to 212 normal controls on serum BDNF and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Serum BDNF levels were significantly decreased in T2DM patients compared to normal controls (p < 0.001). The total score and nearly all indexes (all p < 0.01) except for attention and visuospatial/constructional indexes (all p > 0.05) of RBANS were markedly lower in T2DM than controls. There was a positive relationship between serum BDNF and delayed memory in patients with T2DM. Our results suggest that BDNF may play a role in the pathophysiology of cognitive deficits, especially delayed memory in T2DM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据